Trials / Completed
CompletedNCT01285596
A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex
An Open-label, Randomized, 2-way Crossover Study to Evaluate the Pharmacokinetics of Mirabegron and Its Metabolites in Healthy Young and Elderly Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Young and elderly, male and female subjects are each given 2 different doses of mirabegron for 7 days each. Levels of mirabegron in the blood are assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirabegron | oral |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2011-01-28
- Last updated
- 2013-07-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01285596. Inclusion in this directory is not an endorsement.